1-5 of 5
Richard Schlenk, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Midostaurin in Combination with Intensive Induction and As Single Agent Maintenance Therapy after Consolidation Therapy with Allogeneic Hematopoietic Stem Cell Transplantation or High-Dose Cytarabine (NCT01477606)

Richard Schlenk, MD, Konstanze Döhner, MD, Helmut Salih, MD, Andrea Kündgen, Walter Fiedler, MD, Hans-Juergen Salwender, MD, Joerg Westermann, MD, Katharina S. Götze, MD, Heinz-August Horst, MD PhD, Gerald Wulf, MD, Michael Lübbert, MD, Doris Kraemer, MD, Thomas Kindler, MD, Mark Ringhoffer, MD, Peter Brossart, MD, Gerhard Held, MD, Richard Greil, Thomas Südhoff, MD, Anja Münnich, Daniela Weber, Verena I. Gaidzik, MD, Maria-Veronica Teleanu, MD, Peter Paschka, MD, Frauke Theis, Michael Heuser, MD, Felicitas Thol, MD, Axel Benner, Arnold Ganser, Hartmut Döhner, Prof. Dr.
Journal: Blood
Blood (2015) 126 (23): 322.
https://doi.org/10.1182/blood.V126.23.322.322
Published: 2015
Journal Articles

Gene Mutations and Treatment Outcome in CLL Patients Treated with Chlorambucil (Chl) or Ofatumumab-Chl (O-Chl): Results from the Phase III Study COMPLEMENT1 (OMB110911)

Eugen Tausch, MD, Christina Galler, Richard Schlenk, MD, Peter Hillmen, MBChB, PhD, Fritz Offner, MD, Ann Janssens, MD, K Govindbabu, MD, Jiri Mayer, MD, Sebastian Grosicki, MD, Panagiotis Panagiotidis, Daniel Mertens, PhD, Astrid McKeown, PhD, Ira Gupta, Hartmut Döhner, MD, Stephan Stilgenbauer, MD
Journal: Blood
Blood (2014) 124 (21): 1992.
https://doi.org/10.1182/blood.V124.21.1992.1992
Published: 2014
Journal Articles

NPM1 Splice Variant R2 Reveals Biological and Clinical Consequences of Prognostic Value in Acute Myeloid Leukemia

Krzysztof Giannopoulos, MD PhD, Malgorzata Zajac, Anna Dolnik, Matthias Schunn, Stephany Correa, Eliza Glodkowska-Mrowka, MD, Reddy Chakkarappan Sundaram, Olga Jankowska-Lecka, Richard Schlenk, MD, Konstanze Dohner, MD, Lars Bullinger, MD
Journal: Blood
Blood (2014) 124 (21): 2338.
https://doi.org/10.1182/blood.V124.21.2338.2338
Published: 2014
Journal Articles

Phase I/II Study of BI 2536, An Intravenous Polo-Like Kinase-1 (Plk-1) Inhibitor, in Elderly Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML): First Results of a Multi-Center Trial

C. Müller-Tidow, MD, Gesine Bug, MD, Richard Schlenk, MD, Michael Lübbert, MD, PhD, Alwin Krämer, MD, Juergen Krauter, MD, David Nachbaur, MD, Peter Valent, MD, Tillmann Taube, MD, Gerd Munzert, MD, Kang-Hun Lee, MD, Hartmut Dohner, MD
Journal: Blood
Blood (2008) 112 (11): 2973.
https://doi.org/10.1182/blood.V112.11.2973.2973
Published: 2008
Journal Articles

Prognosis of Adult Patients ≤60 Years with AML and Aberrations of Chromosome 11q23: Pooled Data Analysis of the AML-SG and SHG-Dresden Study Groups.

Jürgen Krauter, MD, Irina Schäfer, Anke Kohlenberg, MD, Katharina Wagner, MD, Gerhard Heil, MD, Markus Schaich, MD, Gerhard Ehninger, MD, Konstanze Döhner, MD, Hartmut Döhner, MD, Richard Schlenk, MD, Arnold Ganser, MD
Journal: Blood
Blood (2005) 106 (11): 2360.
https://doi.org/10.1182/blood.V106.11.2360.2360
Published: 2005